Description

Midodrine Hydrochloride Tablets (2.5 mg / 5 mg / 10 mg)

Healthy Inc is a specialized global supplier and exporter of advanced cardiovascular, neurology, and dysautonomia-support therapeutics. We provide ultra-high-purity, kinetically optimized Midodrine Hydrochloride Uncoated Tablets (2.5 mg / 5 mg / 10 mg), manufactured in WHO–GMP certified, high-precision immediate-release oral solid dosage facilities. This “Selective Alpha-1 Adrenergic Agonist Prodrug” is a high-value, highly critical export to cardiology centers, specialized dysautonomia clinics, geriatric networks, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated, life-saving intervention for severe, symptomatic Orthostatic Hypotension and recurrent syncope.

Product Overview

This highly advanced formulation utilizes a specialized “prodrug” delivery system. It acts as an internal pressure suit, physically constricting the peripheral blood vessels to fight gravity and forcefully pump blood back into the brain and heart when the patient’s autonomic nervous system has failed.

The “Systemic Vasoconstrictor & Anti-Syncope” Specialist:

• Mechanism 1 (The Prodrug Hydrolysis Engine): Midodrine is an inactive prodrug. Upon swallowing, it rapidly absorbs and is enzymatically cleaved by the liver and systemic circulation into desglymidodrine, the true active metabolite. This sophisticated delivery ensures a smooth, sustained elevation of blood pressure rather than the violent, dangerous spikes caused by direct-acting IV vasopressors.
• Mechanism 2 (Selective Alpha-1 Activation): Desglymidodrine violently and specifically binds to Alpha-1 adrenergic receptors located on the smooth muscle lining the arterioles and veins. It forces these vessels to constrict (vasoconstriction). By shrinking the capacity of the vascular system, it massively increases venous return to the heart and elevates standing blood pressure, instantly reversing the dizziness, blurred vision, and fainting associated with orthostatic hypotension.
• The Brain & Heart Sparing Advantage: Unlike older, non-specific stimulants (like Ephedrine), desglymidodrine does not cross the blood-brain barrier (no central nervous system jitteriness or insomnia) and does not stimulate Beta-1 receptors in the heart (no direct cardiac pacing). It is a pure, highly targeted vascular clamp.

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Cardiology Distributors, and Hospital Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Rapid-Clearing Pharmacokinetic Engineering (CRITICAL COMPLIANCE): The clinical safety of Midodrine is entirely dependent on its speed. The drug must absorb, work, and leave the body *before* the patient lies down to sleep, otherwise they face lethal hypertension. Our facilities utilize advanced high-shear direct compression to create a tablet that disintegrates within minutes of ingestion. This guarantees a predictable, short-acting clinical effect (lasting 2 to 3 hours) that allows patients to stand safely during the day without the drug lingering in their system at night.

Therapeutic Indications (Human Use)

Indicated for the targeted, highly specialized management of severe hemodynamic instability:

• Symptomatic Orthostatic Hypotension: Treatment of severe dizziness, fainting, and blurred vision caused by a profound drop in blood pressure upon standing, often secondary to diabetic autonomic neuropathy or Parkinson’s disease.
• Postural Orthostatic Tachycardia Syndrome (POTS): Highly utilized off-label globally to induce peripheral vasoconstriction and prevent the severe reflex tachycardia associated with this dysautonomic condition.
• Dialysis-Induced Hypotension: Used as a prophylactic oral vasopressor to prevent massive blood pressure crashes during hemodialysis sessions.

Dosage & Administration

Recommended Dosage (Strictly as per Cardiologist/Neurologist Guidelines):

• Standard Adult Dosing: Typically 10 mg taken orally 3 times daily, spaced roughly 3 to 4 hours apart during the daytime hours when the patient is upright and active.
• The 4-Hour Rule (FATAL WARNING): The final dose of the day MUST be taken at least 4 hours before bedtime. Taking the drug right before sleeping, or lying down flat after a dose, is strictly prohibited due to the risk of severe supine hypertension.
• Administration: Can be taken with or without food.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• BLACK BOX WARNING (Severe Supine Hypertension): Midodrine can cause marked elevation of blood pressure when lying down (supine hypertension), which increases the risk of stroke, myocardial infarction, and death. Patients must be heavily counseled to sleep with the head of their bed elevated and must never take the drug if they plan to lie flat.
• Urinary Retention (Alpha-1 Squeezing Effect): Because Alpha-1 receptors also control the sphincter muscle of the bladder, Midodrine actively tightens the bladder neck. It is contraindicated in patients with acute urinary retention or severe BPH, as it can completely halt urination.
• Severe Reflex Bradycardia: As the drug violently raises blood pressure, the body may attempt to compensate by drastically slowing the heart rate via the vagus nerve. Heart rate must be monitored, especially in patients taking concurrent beta-blockers or digoxin.
• “Goosebumps” and Scalp Tingling: A very common, harmless side effect (piloerection) caused by the drug contracting the tiny muscles attached to hair follicles on the skin.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Dysautonomia Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Cardiovascular, Neurological, and Vasopressor Formulations. Whether you are looking for a reliable Government Tender Supplier for geriatric care in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely, secure delivery of highly stable, WHO-GMP certified products.